A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosine-1-phosphate Receptor Subtype 1 Agonist, in Healthy Volunteers. A Study to Assess the Relative Bioavailability of Different Formulations of GSK2018682, a Sphingosin ...
An Open-label, Randomised, Crossover Study to Assess the Relative Bioavailability of Different 2mg Formulations of GSK2018682(S1P1 Agonist) in Healthy Volunteers An Open-label, Randomised, Crossover Study to Assess the Relative Bioavailability of Different 2mg F ...